🇺🇸 FDA
Patent

US 12304912

Fused bicyclic RAF inhibitors and methods for use thereof

granted A61KA61K45/06A61P

Quick answer

US patent 12304912 (Fused bicyclic RAF inhibitors and methods for use thereof) held by Jazz Pharmaceuticals Ireland Limited expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals Ireland Limited
Grant date
Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K45/06, A61P, A61P35/00